The Mitochondriotropic effects of L-carnitine and its esters in the central nervous system
Free radicals are unstable, meaning they have unpaired electrons and seek out other electrons to pair with
GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly
1012 In the present study, we aimed to evaluate the efficacy and safety of an oral glutathione supplement (Lynae Mazthione
When it comes to obesity, Seeley said, your flavor of metabolic disease will be different than the next persons. Obesity drugs of the future may finally reflect that diversity, too